Transcripts PharmaEssentia Corporation

Stocks

End-of-day quote Taiwan S.E. 24/09/2026			5-day change	1st Jan Change
1,155.00 ^TWD	-1.70%		-2.12%	+172.60%

09-18	PharmaEssentia Gets Experts Board's Recommendation to Continue Phase 3 Myelofibrosis Drug Trial	MT
09-03	PharmaEssentia Receives FDA Approval For Ropeginterferon Alfa-2b-njft For Essential Thrombocythemia	CI

No results match your criteria

PharmaEssentia receives China NMPA approval for key Phase III clinical trial

March 27, 2025 at 01:48 pm